A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. (Q34505708)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. |
scientific article |
Statements
A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group (English)
Martín G
Rayón C
Esteve J
González M
Díaz-Mediavilla J
Bolufer P
Barragán E
González JD
Colomer D
Chillón C
Rivas C
Gómez T
Ribera JM
Bornstein R
Román J
Calasanz MJ
Arias J
Alvarez C
Ramos F
1 November 1999